Groundbreaking clinical trials published in late 2023 and 2024 show that semaglutide, approved in 2019 for treating diabetes and in 2021 for weight management, also reduces rates of heart disease and kidney disease, and reduces tissue and systemic inflammation
I struggled with what my body should look like, being happy with it and being fulfilled by what it could do
Sarcopenia: an undiagnosed condition in older adults
Additionally, fibronectin, an essential component of the ECM involved in structural support, exhibited a substantial decrease in both IHC and IF post-treatment
The TRIUMPH phase 3 programme is recruiting internationally, and UK sites may be involved
Laboratory studies in photoaging models show that combined peptide approaches addressing multiple regenerative pathways produce superior outcomes compared to single-agent interventions, with improvements in collagen organization, elastin fiber quality, hyaluronic acid content, and overall dermal architecture